Cites del registre
Cita APA (7th ed.)
Besova, N. S., Titova, Т. А., Tryakin, А. А., Artamonova, Е. V., Obarevich, Е. S., Stroyakovskiy, D. L., . . . Stilidi, I. S. (2021). Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting. Remedium Group LLC.
Copiat
No s'ha pogut copiar
Cita Chicago (17th ed.)
Besova, N. S., Т. А Titova, А. А Tryakin, Е. V. Artamonova, Е. S. Obarevich, D. L. Stroyakovskiy, О. Е Kalinin, i I. S. Stilidi. Ramucirumab with Paclitaxel or FOLFIRI as Second-line Treatment in Docetaxel-pre-treated Patients with Metastatic Gastric Cancer in Real-world Setting. Remedium Group LLC, 2021.
Copiat
No s'ha pogut copiar
Cita MLA (9th ed.)
Besova, N. S., et al. Ramucirumab with Paclitaxel or FOLFIRI as Second-line Treatment in Docetaxel-pre-treated Patients with Metastatic Gastric Cancer in Real-world Setting. Remedium Group LLC, 2021.
Copiat
No s'ha pogut copiar
Atenció: Aquestes cites poden no estar 100% correctes.